Novo Nordisk’s Wegovy weight loss drug wins UK approval for use as a heart treatment
The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk’s Wegovy drug to reduce the risk of obese adults suffering from serious heart problems or strokes.
